Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Schizophrenia

  Free Subscription


10.04.2017

1 Acta Psychiatr Scand
2 Am J Med Genet B Neuropsychiatr Genet
1 Am J Psychiatry
5 Br J Psychiatry
1 J Clin Psychopharmacol
1 Mol Psychiatry
1 Neuropsychology
1 Neuropsychopharmacology
1 PLoS One
4 Psychiatry Res
2 Psychol Med
4 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Psychiatr Scand

  1. WALTON E, Hibar DP, van Erp TG, Potkin SG, et al
    Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium.
    Acta Psychiatr Scand. 2017;135:439-447.
    PubMed     Text format     Abstract available


    Am J Med Genet B Neuropsychiatr Genet

  2. DE SENA CORTABITARTE A, Degenhardt F, Strohmaier J, Lang M, et al
    Investigation of SHANK3 in schizophrenia.
    Am J Med Genet B Neuropsychiatr Genet. 2017 Mar 28. doi: 10.1002/ajmg.b.32528.
    PubMed     Text format     Abstract available

  3. CUI X, Niu W, Kong L, He M, et al
    Can lncRNAs be indicators for the diagnosis of early onset or acute schizophrenia and distinguish major depressive disorder and generalized anxiety disorder?-A cross validation analysis.
    Am J Med Genet B Neuropsychiatr Genet. 2017 Mar 28. doi: 10.1002/ajmg.b.32521.
    PubMed     Text format     Abstract available


    Am J Psychiatry

  4. LAVRETSKY H
    Hallucinations Predict Relapse After Discontinuation of Risperidone in Patients With Alzheimer's Disease and Psychosis or Agitation.
    Am J Psychiatry. 2017;174:307-308.
    PubMed     Text format    


    Br J Psychiatry

  5. WOOD SJ
    Autism and schizophrenia: one, two or many disorders?
    Br J Psychiatry. 2017;210:241-242.
    PubMed     Text format     Abstract available

  6. SAMARA M, Leucht S
    Clozapine in treatment-resistant schizophrenia.
    Br J Psychiatry. 2017;210:299.
    PubMed     Text format    

  7. BHAVSAR V
    EMDR Therapy for Schizophrenia and Other Psychoses.
    Br J Psychiatry. 2017;210:304.
    PubMed     Text format    

  8. CHANG WC, Kwong VW, Lau ES, So HC, et al
    Sustainability of treatment effect of a 3-year early intervention programme for first-episode psychosis.
    Br J Psychiatry. 2017 Apr 6. pii: bjp.bp.117.198929.
    PubMed     Text format     Abstract available

  9. HASSIOTIS A, Noor M, Bebbington P, Afia A, et al
    Borderline intellectual functioning and psychosis: Adult Psychiatric Morbidity Survey evidence.
    Br J Psychiatry. 2017 Apr 6. pii: bjp.bp.116.190652.
    PubMed     Text format     Abstract available


    J Clin Psychopharmacol

  10. ISMAIL Z, Peters-Strickland T, Miguelez M, Baker RA, et al
    Aripiprazole Once-Monthly in the Treatment of Acute Psychotic Episodes in Schizophrenia: Post Hoc Analysis of Positive and Negative Syndrome Scale Marder Factor Scores.
    J Clin Psychopharmacol. 2017 Apr 5. doi: 10.1097/JCP.0000000000000710.
    PubMed     Text format     Abstract available


    Mol Psychiatry

  11. HADAR R, Bikovski L, Soto-Montenegro ML, Schimke J, et al
    Early neuromodulation prevents the development of brain and behavioral abnormalities in a rodent model of schizophrenia.
    Mol Psychiatry. 2017 Apr 4. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


    Neuropsychology

  12. UREN J, Cotton SM, Killackey E, Saling MM, et al
    Cognitive Clusters in First-Episode Psychosis: Overlap With Healthy Controls and Relationship to Concurrent and Prospective Symptoms and Functioning.
    Neuropsychology. 2017 Apr 3. doi: 10.1037/neu0000367.
    PubMed     Text format     Abstract available


    Neuropsychopharmacology

  13. EISENBERG DP, Yankowitz L, Ianni AM, Rubinstein DY, et al
    Presynaptic Dopamine Synthesis Capacity in Schizophrenia and Striatal Blood Flow Change During Antipsychotic Treatment and Medication-Free Conditions.
    Neuropsychopharmacology. 2017 Apr 7. doi: 10.1038/npp.2017.
    PubMed     Text format     Abstract available


    PLoS One

  14. GUO W, Cai Y, Zhang H, Yang Y, et al
    Association of ARHGAP18 polymorphisms with schizophrenia in the Chinese-Han population.
    PLoS One. 2017;12:e0175209.
    PubMed     Text format     Abstract available


    Psychiatry Res

  15. WUSTEN C, Lincoln TM
    The association of family functioning and psychosis proneness in five countries that differ in cultural values and family structures.
    Psychiatry Res. 2017;253:158-164.
    PubMed     Text format     Abstract available

  16. RAFFARD S, Bortolon C, Stephan Y, Capdevielle D, et al
    Personality traits are associated with the valence of future imagined events in individuals with schizophrenia.
    Psychiatry Res. 2017;253:138-141.
    PubMed     Text format     Abstract available

  17. WU XJ, Zeng LL, Shen H, Yuan L, et al
    Functional network connectivity alterations in schizophrenia and depression.
    Psychiatry Res. 2017;263:113-120.
    PubMed     Text format     Abstract available

  18. KALMADY SV, Shivakumar V, Arasappa R, Subramaniam A, et al
    Clinical correlates of hippocampus volume and shape in antipsychotic-naive schizophrenia.
    Psychiatry Res. 2017;263:93-102.
    PubMed     Text format     Abstract available


    Psychol Med

  19. KNAPP F, Viechtbauer W, Leonhart R, Nitschke K, et al
    Planning performance in schizophrenia patients: a meta-analysis of the influence of task difficulty and clinical and sociodemographic variables.
    Psychol Med. 2017 Apr 7:1-15. doi: 10.1017/S0033291717000459.
    PubMed     Text format     Abstract available

  20. CHIEN WT, Bressington D, Yip A, Karatzias T, et al
    An international multi-site, randomized controlled trial of a mindfulness-based psychoeducation group programme for people with schizophrenia.
    Psychol Med. 2017 Apr 4:1-16. doi: 10.1017/S0033291717000526.
    PubMed     Text format     Abstract available


    Schizophr Res

  21. ADDINGTON J, Piskulic D, Liu L, Lockwood J, et al
    Comorbid diagnoses for youth at clinical high risk of psychosis.
    Schizophr Res. 2017 Mar 31. pii: S0920-9964(17)30183.
    PubMed     Text format     Abstract available

  22. TSENG HH, Chen KC, Chen PS, Lee IH, et al
    Dopamine transporter availability in drug-naive patients with schizophrenia and later psychotic symptoms severity.
    Schizophr Res. 2017 Mar 29. pii: S0920-9964(17)30174.
    PubMed     Text format    

  23. WANG LJ, Lin PY, Lee Y, Huang YC, et al
    Increased serum levels of cysteine in patients with schizophrenia: A potential marker of cognitive function preservation.
    Schizophr Res. 2017 Mar 28. pii: S0920-9964(17)30181.
    PubMed     Text format     Abstract available

  24. TAN EJ, Rossell SL
    Formal thought disorder and neurocognition in schizophrenia: The question of individual mechanisms.
    Schizophr Res. 2017 Mar 28. pii: S0920-9964(17)30179.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: